<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04981236</url>
  </required_header>
  <id_info>
    <org_study_id>4-2021-0725</org_study_id>
    <nct_id>NCT04981236</nct_id>
  </id_info>
  <brief_title>Pericapsular Nerve Group (PENG) Block Versus Periarticular Injection for Pain Management After Total Hip Arthroplasty</brief_title>
  <official_title>Pericapsular Nerve Group (PENG) Block Versus Periarticular Injection for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate pain control after total hip arthroplasty is crucial for early ambulation and&#xD;
      patient satisfaction. The pericapsular nerve group (PENG) block has been recently introduced&#xD;
      a new technique for blockade of the articular branches of the femoral, obturator and&#xD;
      accessory obturator nerves. PENG block provides sufficient analgesia but it is still the&#xD;
      potential for quadriceps weakness that might delay ambulation. Periarticular injection has&#xD;
      attached attention as an effective analgesic modality with a low prevalence of adverse&#xD;
      effects. The investigators will compare ultrasound-guided PENG block with periarticular&#xD;
      injection in patients undergoing total hip arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 17, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 23, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric rating scale pain score</measure>
    <time_frame>up to 48 hours after the surgery</time_frame>
    <description>Pain intensity at rest and during 45-degree passive flexion of the hip with the ipsilateral knee flexed naturally will be evaluated by an 11-point numeric rating scale (NRS: 0 = no pain, 10 = worst imaginable pain) 1, 6, 24, and 48 hours after the surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quadriceps muscle strength</measure>
    <time_frame>up to 24 hours postoperatively</time_frame>
    <description>Quadriceps muscle strength will be measured by the dynamometer before the surgery and at 6, and 24 hours postoperatively (both legs)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Total Hip Arthroplasty</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Pericapsular nerve group block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receiving pericapsular nerve group block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periarticular block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receiving periarticular block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pericapsular nerve group block</intervention_name>
    <description>A curvilinear 2-5MHz ultrasound probe will be initially placed in a transverse plane over the anterior superior iliac spine and then aligned with the pubic ramus by rotating the probe counterclockwise approximately 45 degrees. In this view, the iliopubic eminence, the iliopsoas muscle and tendon, the femoral artery, and pectineus muscle will be observed. A 22-gauge, 80-mm needle will be inserted from lateral to medial in an in-plane approach to place the tip in the musculofascial plane between the psoas tendon anteriorly and the pubic ramus posteriorly. A total volume of 20 ml of ropivacaine 0.3% will be injected.</description>
    <arm_group_label>Pericapsular nerve group block</arm_group_label>
    <other_name>PENG block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Periarticular block</intervention_name>
    <description>The periarticular injection solution contained 20mL of 7.5 mg/mL ropivacaine, 30mg of ketorolac, and 0.3mL of 1.0 mg/mL epinephrine. These agents were mixed with normal saline to a combined volume of 50mL. The surgeon injected this mixture into the tensor fascia lata, subcutaneous tissues, abductors, short external rotators muscles, and structures in the capsule.</description>
    <arm_group_label>Periarticular block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Aged 19 years old or older&#xD;
&#xD;
          2. American Society of Anesthesiologists Physical Status 1-3&#xD;
&#xD;
          3. Scheduled for elective unilateral total hip arthroplasty&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Allergy or intolerance to any of the drugs used in the study&#xD;
&#xD;
          2. Hepatic or renal insufficiency&#xD;
&#xD;
          3. Opioid dependency&#xD;
&#xD;
          4. Coagulopathy&#xD;
&#xD;
          5. Pre-existing neurologic or anatomic deficits in the lower extremities&#xD;
&#xD;
          6. Severe psychiatric illness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yong Seon Choi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yong Seon Choi</last_name>
    <phone>82-2-2224-3919</phone>
    <email>yschoi@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Cardiac Anesthesiology, Department of Anesthesiology and Pain Medicine, Cardiovascular Hospital, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Seon Choi</last_name>
      <phone>82-2-2224-3919</phone>
      <email>yschoi@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 22, 2021</study_first_submitted>
  <study_first_submitted_qc>July 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

